FDA
-
-
-
-
-
-
-
Bluejay Diagnostics closes $8.5 million private placement
-
-
-
-
-
-
-
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
-
-
-
-
-
-
-
Bluejay Diagnostics implements 1-for-4 reverse stock split
-
-
-
-
-
-
-
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update
-
-
-
-
-
-
-
bluejay Diagnostics (BJDX): SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
-
-
-
-
-
-
-
bluejay Diagnostics (BJDX) Initiates Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


